Picture Fairtec GmbH Worldwide Event Solutions 600x60px

News > All

Total search results: 7149 | Ordered by Date (descending)
1 2 3 ... 70 71 72  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Immunic AG. (12/12/17). "Press Release: Immunic Therapeutics Successfully Completes Two Phase 1 Studies for IMU-838". Planegg-Martinsried. 2017-12-12
NorthSea Therapeutics B.V.. (12/12/17). "Press Release: NorthSea Therapeutics Secures €25 Million Funding for Clinical Development of Promising NASH Drug". Naarden. 2017-12-12
Adrenomed AG. (12/11/17). "Press Release: Adrenomed AG Doses First Patient in Proof of Concept Study with Adrecizumab to Treat Patients with Early Septic Shock". Hennigsdorf. 2017-12-11
Hookipa Biotech AG. (12/11/17). "Press Release: Hookipa Biotech Raises $60 Million (€50 Million) in an Oversubscribed Round C Financing". Vienna. 2017-12-11
Argen-X N.V. (Argenx). (12/11/17). "Press Release: Argenx Announces Launch of Proposed Public Offering in the United States". Breda & Ghent. 2017-12-11
Argen-X N.V. (Argenx). (12/11/17). "Press Release: Argenx Reports Positive Topline Results from Phase 2 Proof-of-Concept Trial of ARGX-113 (efgartigimod) in Generalized Myasthenia Gravis". Breda & Ghent. 2017-12-11
Idex Corporation. (12/11/17). "Press Release: Idex Corporation to Acquire thinXXS Microtechnology AG". Lake Forest, IL. 2017-12-11
Discngine S.A.S.. (12/11/17). "Press Release: Discngine Raises €1.1 Million ($1.3M) in Series A Funding Round". Paris. 2017-12-11
CRISPR Therapeutics AG. (12/10/17). "Press Release: CRISPR Therapeutics Announces Oral Presentation of New Data on CTX001, a CRISPR Gene-Edited Therapy for ß-Thalassemia and Sickle Cell Disease, at the ASH Annual Meeting". Zug & Cambridge, MA. 2017-12-10
Medivir AB. (12/10/17). "Press Release: Medivir Announces Janssen Decision to Terminate Its Simeprevir License effective June 2018". Stockholm. 2017-12-10
bio.logis Genetic Information Management GmbH. (12/8/17). "Press Release: bio.logis GIM GmbH Concludes a Distribution Agreement with PGS.Holland BV". 2017-12-08
Erytech Pharma. (12/8/17). "Press Release: Erytech Reports Top-line Results of Phase 2b Study of Eryaspase for the Treatment of AML". Lyon. 2017-12-08
ThromboGenics N.V.. (12/8/17). "Press Release: Patient Enrolment in Phase II CIRCLE Study Evaluating THR-409 (ocriplasmin) for Non-Proliferative Diabetic Retinopathy (NPDR) Discontinued Due to Slow Recruitment Rate". Leuven. 2017-12-08
Qiagen N.V.. (12/8/17). "Press Release: Qiagen to Transfer U.S. Listing of Global Shares to NYSE". Germantown, MD & Hilden. 2017-12-08
Bluebird Bio, Inc.. (12/7/17). "Press Release: Bluebird Bio and TC BioPharm Announce Strategic Collaboration to Research and Develop Gamma Delta CAR T Cell Product Candidates for Cancer Immunotherapy". Cambridge, MA & Edinburgh. 2017-12-07
Abivax S.A.. (12/7/17). "Press Release: Abivax to Present in Plenary Session at the 8th International Conference on HIV Persistence during Therapy". Paris. 2017-12-07
CRISPR Therapeutics AG. (12/7/17). "Press Release: CRISPR Therapeutics Submits First Clinical Trial Application for a CRISPR Gene-Edited Therapy, CTX001 in ß-thalassemia". Zug & Cambridge, MA. 2017-12-07
Cell Medica Ltd.. (12/7/17). "Press Release: Cell Medica Announces Appointment of Industry Leader Dr Annalisa Jenkins as Chair". 2017-12-07
Coulter Partners. (12/7/17). "Press Release: Coulter Partners Helps Secure Industry Leader, Dr Annalisa Jenkins as Chair for Cell Medica". 2017-12-07
Agendia. (12/7/17). "Press Release: Agendia and UZ Leuven Partner to Co-Validate MammaPrint BluePrint Breast Cancer Risk of Recurrence and Molecular Subtyping Kit Ahead of European Launch". Irvine, CA & Amsterdam. 2017-12-07
Novartis AG. (12/7/17). "Press Release: Novartis Tender Offer for Advanced Accelerator Applications Commences". Basel. 2017-12-07
Pieris Pharmaceuticals, Inc.. (12/7/17). "Press Release: Pieris Pharmaceuticals Announces Ethics and Regulatory Clearance to Begin Clinical Testing of Inhaled Respiratory Program, PRS-060/AZD1402". Boston, MA. 2017-12-07
ERS Genomics Ltd.. (12/6/17). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to Charles River". Dublin. 2017-12-06
Biocartis Group N.V.. (12/6/17). "Press Release: Disclosure of a Transparency Notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings)". Mechelen. 2017-12-06
Genoscience Pharma S.A.S.. (12/6/17). "Press Release: Genoscience Pharma Receives FDA Approval for Phase Ib/IIa Study of GNS561 in Liver Cancer". Marseille. 2017-12-06
BGI. (12/6/17). "Press Release: BGI and Hummingbird Diagnostics Sign Memorandum of Understanding". Shenzhen & Heidelberg. 2017-12-06
Leti. (12/6/17). "Press Release: Innovation in the Diagnosis of Breast Cancer". 2017-12-06
Paion AG. (12/6/17). "Press Release: Jürgen Beck, MD, Appointed as Chief Development Officer at Paion AG". Aachen. 2017-12-06
Proteros Biostructures GmbH. (12/6/17). "Press Release: Proteros Names Dave Lemus as New Executive Board Member". Munich. 2017-12-06
Robocath S.A.S.. (12/6/17). "Press Release: Robocath Raises a Total of €6.4 million ($7.6M) in 2017". 2017-12-06
Advicenne S.A.. (12/5/17). "Press Release: Advicenne Raises €27 Million in Successful IPO on Euronext Paris [THIS PRESS RELEASE MAY NOT BE PUBLISHED, DISSEMINATED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY TO THE USA, AUSTRALIA, CANADA OR JAPAN]". Nîmes. 2017-12-05
Probiodrug AG. (12/5/17). "Press Release: Probiodrug and Crossbeta Biosciences Extend Their Strategic Partnership in the Field of Alzheimer’s Disease Biomarkers". Halle (Saale) & Utrecht. 2017-12-05
Medigene AG. (12/5/17). "Press Release: Medigene Sells US-rights for Veregen and Raises Financial Guidance 2017". Martinsried. 2017-12-05
ERS Genomics Ltd.. (12/5/17). "Press Release: Horizon Extends Industry-Leading Gene Editing IP Portfolio through Expansion of CRISPR License Rights with ERS Genomics". Dublin & Cambridge. 2017-12-05
Agendia. (12/5/17). "Press Release: Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint BluePrint Breast Cancer Kit Co-Validation Study". Irvine, CA, Amsterdam & Paris. 2017-12-05
Novo Nordisk A/S. (12/5/17). "Press Release: Ozempic (semaglutide) Approved in the US". Bagsvaerd. 2017-12-05
Idorsia Ltd.. (12/4/17). "Press Release: Idorsia Announces Collaboration with Janssen Biotech on Aprocitentan (ACT-132577)". Allschwil. 2017-12-04
Sanofi S.A.. (12/4/17). "Press Release: Sanofi’s Toujeo Met Main Objective in Head-to-head Study versus Insulin Degludec". Paris. 2017-12-04
Biocartis Group N.V.. (12/4/17). "Press Release: Biocartis and Amgen Sign Companion Diagnostic Agreement for Idylla™ RAS Biomarker Tests". Mechelen. 2017-12-04
Ncardia. (12/4/17). "Press Release: Ncardia and Evotec Entered a Licencing Agreement for Disease Modelling Using iPS Cells". Gosselies. 2017-12-04
Silence Therapeutics plc. (12/4/17). "Press Release: Partial Disposal of Arrowhead Common Shares". 2017-12-04
Leti. (12/4/17). "Press Release: Leti Researcher Reappointed Head of the European Technology Platform for Nanomedicine". 2017-12-04
Sanofi S.A.. (12/1/17). "Press Release: Sanofi Ends Development of Clostridium Difficile Vaccine". Paris. 2017-12-01
Active Biotech AB. (12/1/17). "Press Release: Active Biotech Announce Results in ARPEGGIO Phase II Trial with Laquinimod in Primary Progressive MS". Lund. 2017-12-01
Basilea Pharmaceutica Ltd.. (12/1/17). "Press Release: Basilea Extends Existing License Agreement with Pfizer for Antifungal Cresemba (isavuconazole) to China and Asia Pacific". Basel. 2017-12-01
Evotec AG. (12/1/17). "Press Release: Evotec Receives Clinical Milestone as Part of Its Discovery Alliance with Boehringer Ingelheim". Hamburg. 2017-12-01
Bayer AG. (12/1/17). "Press Release: CFIUS Completes Review of Proposed Merger of Bayer and Monsanto". Leverkusen & St. Louis, MI. 2017-12-01
Nexstim Oyj. (12/1/17). "Press Release: Nexstim Plc Appoints Steve Beller as Vice President and General Manager, North America". Helsinki. 2017-12-01
Polyganics. (12/1/17). "Press Release: Polyganics Awarded €1.2 Million to Complete Clinical Development of Dura Sealant Patch". Groningen. 2017-12-01
Johnson & Johnson. (11/30/17). "Press Release: Johnson & Johnson and Partners Announce First Efficacy Study for Investigational Mosaic HIV-1 Preventive Vaccine". New Brunswick, NJ. 2017-11-30
Agena Bioscience, Inc.. (11/30/17). "Press Release: Agena Bioscience’s Liquid Biopsy Technology Awarded Horizon 2020 Grant by European Union". San Diego, CA. 2017-11-30
MorphoSys AG. (11/30/17). "Press Release: MorphoSys Signs Regional License Agreement for Antibody MOR202 with I-Mab". Planegg. 2017-11-30
Probiodrug AG. (11/30/17). "Press Release: Probiodrug Reports Third Quarter 2017 Business Update". Halle (Saale). 2017-11-30
Bayer AG. (11/30/17). "Press Release: Bayer Combines Pharmaceutical Research and Development Unit [Not intended for U.S. and UK Media]". Leverkusen. 2017-11-30
Bayer AG. (11/30/17). "Press Release: Phase III Trial of Radium-223 Dichloride in Combination with Abiraterone Acetate and Prednisone/Prednisolone for Patients with Metastatic Castration-resistant Prostate Cancer Unblinded Early [Not intended for U.S. an 2017-11-30
Carrick Therapeutics Ltd.. (11/30/17). "Press Release: Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of iIts Oral CDK7 inhibitor – CT7001". 2017-11-30
Selvita S.A.. (11/30/17). "Press Release: Selvita Promotes Edyta Jaworska to the Management Board to Strengthen Development in Integrated Drug Discovery Services". Krakow. 2017-11-30
Leti. (11/30/17). "Press Release: Leti Develops Meg Technology To Improve Diagnosis Of Epilepsy and Guide Surgeons During Brain Surgery". 2017-11-30
Oasmia Pharmaceutical AB. (11/30/17). "Press Release: Oasmia Has Completed a Private Placement of New Convertible instruments in a Total Amount of SEK 28,000,000". 2017-11-30
Sanofi S.A.. (11/29/17). "Press Release: Sanofi Updates Information on Dengue Vaccine. New Analysis of Long-term Dengvaxia Data Found Differences in Vaccine Performance Based on Prior Dengue Infection". Paris. 2017-11-29
Epigenomics AG. (11/29/17). "Press Release: Supervisory Board of Epigenomics AG Appoints Albert Weber as Executive Vice President Finance and a Member of the Management Board (Vorstand)". Berlin & Germantown, MD. 2017-11-29
Bluebird Bio, Inc.. (11/29/17). "Press Release: Bluebird Bio Acquires Manufacturing Facility in North Carolina and Executes Multiple Global Supply Agreements to Enhance Ability to Deliver Gene Therapies to Patients". Cambridge, MA. 2017-11-29
Genedata AG. (11/28/17). "Press Release: New Release of Genedata Selector Revolutionizes Genomic Data Management and Analysis for Key Biopharma Applications". Basel. 2017-11-28
Biocartis Group N.V.. (11/28/17). "Press Release: Biocartis Successfully Raises EUR 80 Million in an Equity Placement [Not for US, AU, CA, JP, ZA or any other jurisdition where prohibited by law]". Mechelen. 2017-11-28
Biocartis Group N.V.. (11/28/17). "Press Release: Biocartis Launches Equity Placement [Not for US, AU, CA, JP, ZA or any other jurisdition where prohibited by law]". Mechelen. 2017-11-28
iOnctura S.A.. (11/28/17). "Press Release: iOnctura Announces Appointment of Leading International Scientific Advisory Board". Geneva. 2017-11-28
Sphere Fluidics Ltd.. (11/27/17). "Press Release: Sphere Fluidics and Geneva Biotech Receive Eurostars Genome Editing Grant". Cambridge & Geneva. 2017-11-27
Medigene AG. (11/27/17). "Press Release: Patient Recruitment Completed for Phase I/II DC Vaccine Trial in AML". Planegg. 2017-11-27
Euformatics Oy. (11/27/17). "Press Release: Euformatics Integrates AMP/ASCO/CAP Variant Guidelines Into omnomicsNGS". Espoo. 2017-11-27
BioMed X GmbH. (11/27/17). "Press Release: BioMed X and Boehringer Ingelheim Start New Joint Research Group in Bacterial Modulation of Innate Immunity". Heidelberg. 2017-11-27
Owlstone Medical Ltd.. (11/27/17). "Press Release: Owlstone Medical’s Breath Biopsy Platform Integrated into GSK’s Phase II Respiratory Disease Clinical Trial". Cambridge. 2017-11-27
Analytik Jena AG. (11/27/17). "Press Release: Analytik Jena and BAM Agree to Cooperate in Research". Jena. 2017-11-27
Teva Pharmaceutical Industries Ltd.. (11/27/17). "Press Release: Teva Announces New Organization Structure and Leadership Changes". Jerusalem. 2017-11-27
Bayer AG. (11/27/17). "Press Release: Bayer Is Expanding Its Collaboration with Bitkom". Leverkusen & Berlin. 2017-11-27
Biocartis Group N.V.. (11/27/17). "Press Release: Biocartis Launches CE-marked IVD RAS Liquid Biopsy Tests Developed under Partnership with Merck KGaA, Darmstadt, Germany". Mechelen. 2017-11-27
LabGenius. (11/24/17). "Press Release: LabGenius Locks Down $3.66m from Top-tier Investors to Harness Evolution". London. 2017-11-24
Royal Philips. (11/24/17). "Press Release: Philips Expands Its Radiology Solutions Portfolio with the Acquisition of Analytical Informatics, Inc.". Amsterdam. 2017-11-24
MorphoSys AG. (11/23/17). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Received Approval for Tremfya (Guselkumab) in Europe for the Treatment of Moderate-to-Severe Plaque Psoriasis". Planegg. 2017-11-23
Royal Philips. (11/23/17). "Press Release: Philips-led Research Consortium Awarded EUR 6.3 Million EU Grant to Develop Integrated Approaches for Personalized Cancer Treatment". Amsterdam. 2017-11-23
Ablynx N.V.. (11/21/17). "Press Release: Results from the Phase III HERCULES Study of Caplacizumab for the Treatment of Acquired TTP Selected for Presentation in the Late-breaking Abstracts Session at the 2017 ASH Annual Meeting". Ghent. 2017-11-21
Johnson & Johnson. (11/21/17). "Press Release: Janssen Submits Application to U.S. FDA to Expand Indication for Darzalex (daratumumab) Combination Therapy for Patients with Newly Diagnosed Multiple Myeloma who are Transplant Ineligible". Raritan, NJ. 2017-11-21
Genmab A/S. (11/21/17). "Press Release: Genmab Announces European Regulatory Submission for Daratumumab in Front Line Multiple Myeloma". Copenhagen. 2017-11-21
Genmab A/S. (11/21/17). "Press Release: Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Front Line Multiple Myeloma". Copenhagen. 2017-11-21
Genmab A/S. (11/21/17). "Press Release: Data from Phase III ALCYONE Study of Daratumumab Accepted for Oral Presentation at Annual Meeting of the American Society of Hematology". Copenhagen. 2017-11-21
Royal Philips. (11/21/17). "Press Release: Philips Showcases New Portfolio of Integrated Digital Imaging Systems and Advanced Informatics at RSNA 2017". Amsterdam. 2017-11-21
Abivax S.A.. (11/20/17). "Press Release: Abivax Enrolls First Ulcerative Colitis Patient in New ABX464 Proof-of-Concept Clinical Trial". Paris. 2017-11-20
Boehringer Ingelheim. (11/20/17). "Press Release: Boehringer Ingelheim Makes Many of Its Best Molecules Openly Available to the Scientific Community via to Unlock Their Full Potential". Ingelheim. 2017-11-20
Calliditas Therapeutics AB. (11/20/17). "Press Release: Surrogate Marker and Design of Calliditas Therapeutics’ IgA Nephropathy Phase 3 Study Agreed with the FDA". Stockholm. 2017-11-20
Cellectis S.A.. (11/20/17). "Press Release: Cellectis Demonstrates Fine and Predictable Tuning of TALEN Gene Editing Targeting to Improve T-cell Adoptive Immunotherapy". New York, NY. 2017-11-20
Jennewein Biotechnologie GmbH. (11/20/17). "Press Release: EU Approval for 2'-fucosyllactose". 2017-11-20
Grifols S.A.. (11/17/17). "Press Release: FDA Approval of Genetic Test for Alpha-1 Deficiency and EMA Approval of Fibrin Sealant". Barcelona. 2017-11-17
Roche. (11/17/17). "Press Release: FDA Approves Roche’s Gazyva for Previously Untreated Advanced Follicular Lymphoma". Basel. 2017-11-17
Roche. (11/17/17). "Press Release: Roche to Acquire Viewics, Inc. to Provide Data-driven Lab Business Analytics and Add further Digital Capabilities along the Laboratory Value Chain". Basel. 2017-11-17
Genmab A/S. (11/17/17). "Press Release: Genmab Achieves USD 50 Million Sales Milestone in Darzalex (daratumumab) Collaboration with Janssen". Copenhagen. 2017-11-17
Ncardia. (11/17/17). "Press Release: Ncardia Announces Completion of €10.5m Investment Round". Gosselies. 2017-11-17
Elpis BioMed Ltd.. (11/16/17). "Press Release: Elpis BioMed Closes Funding Round to Commercialise Novel technology platform for generating human cell types". Cambridge. 2017-11-16
Formycon AG. (11/16/17). "Press Release: Formycon Sets Course for the Future and Confirms Management Board Members until mid-2022". Munich. 2017-11-16
Goodwin Procter LLC. (11/16/17). "Press Release: Intellia Therapeutics Closes $150 Million Public Offering of Common Stock". 2017-11-16
High-Tech Gründerfonds Management GmbH. (11/16/17). "Press Release: EWE Invests in High-Tech Gründerfonds III". 2017-11-16
Molecular Health GmbH. (11/16/17). "Press Release: Molecular Health and U.S. Food and Drug Administration (FDA) Extend Software Collaboration to Drug Safety Prediction". Cambridge, MA. 2017-11-16
1 2 3 ... 70 71 72  next pagenext page


Picture [LSF] – The Business Web Portal 600x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 600x60px

» top


Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px Picture [LSE] – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px